1. Home
  2. IMNM vs ATEN Comparison

IMNM vs ATEN Comparison

Compare IMNM & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • ATEN
  • Stock Information
  • Founded
  • IMNM 2006
  • ATEN 2004
  • Country
  • IMNM United States
  • ATEN United States
  • Employees
  • IMNM N/A
  • ATEN N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • ATEN EDP Services
  • Sector
  • IMNM Health Care
  • ATEN Technology
  • Exchange
  • IMNM Nasdaq
  • ATEN Nasdaq
  • Market Cap
  • IMNM 1.2B
  • ATEN 1.3B
  • IPO Year
  • IMNM 2020
  • ATEN 2014
  • Fundamental
  • Price
  • IMNM $18.12
  • ATEN $16.95
  • Analyst Decision
  • IMNM Strong Buy
  • ATEN Strong Buy
  • Analyst Count
  • IMNM 8
  • ATEN 4
  • Target Price
  • IMNM $25.75
  • ATEN $21.50
  • AVG Volume (30 Days)
  • IMNM 1.4M
  • ATEN 660.6K
  • Earning Date
  • IMNM 11-06-2025
  • ATEN 11-04-2025
  • Dividend Yield
  • IMNM N/A
  • ATEN 1.37%
  • EPS Growth
  • IMNM N/A
  • ATEN 4.68
  • EPS
  • IMNM N/A
  • ATEN 0.69
  • Revenue
  • IMNM $9,679,000.00
  • ATEN $284,406,000.00
  • Revenue This Year
  • IMNM N/A
  • ATEN $10.53
  • Revenue Next Year
  • IMNM $85.36
  • ATEN $7.41
  • P/E Ratio
  • IMNM N/A
  • ATEN $25.29
  • Revenue Growth
  • IMNM N/A
  • ATEN 10.27
  • 52 Week Low
  • IMNM $5.15
  • ATEN $13.81
  • 52 Week High
  • IMNM $18.79
  • ATEN $21.90
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 64.32
  • ATEN 40.33
  • Support Level
  • IMNM $16.11
  • ATEN $16.76
  • Resistance Level
  • IMNM $17.94
  • ATEN $18.80
  • Average True Range (ATR)
  • IMNM 1.26
  • ATEN 0.56
  • MACD
  • IMNM 0.02
  • ATEN -0.07
  • Stochastic Oscillator
  • IMNM 86.56
  • ATEN 8.09

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

Share on Social Networks: